VistaGen Therapeutics
VTGN
VTGN
33 hedge funds and large institutions have $1.82M invested in VistaGen Therapeutics in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 54 closing their positions.
Holders
33
Holders Change
-50
Holders Change %
-60.24%
% of All Funds
0.52%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
11
Reduced
16
Closed
54
Calls
$31K
Puts
–
Net Calls
+$31K
Net Calls Change
+$31K
Top Buyers
1 |
GCP
1
GSA Capital Partners
London,
United Kingdom
|
$372K |
2 |
2
Millennium Management
New York
|
$189K |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$419K |
4 |
4
Goldman Sachs
New York
|
$107K |
5 |
YIH
5
Y-Intercept (HK)
Hong Kong
|
$89.2K |